Engineering an analog-sensitive CDK12 cell line using CRISPR/Cas.
about
Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitorsThe pol II CTD: new twists in the tail.Inhibitors of cyclin-dependent kinases as cancer therapeutics.The code and beyond: transcription regulation by the RNA polymerase II carboxy-terminal domain.The emerging roles of CDK12 in tumorigenesis.CDK regulation of transcription by RNAP II: Not over 'til it's over?Taking Aim at Glycolysis with CDK8 Inhibitors.
P2860
Q37275810-0E759750-D3F2-4C9F-98CE-8F375B1C3EFBQ38948938-308B7DCD-9117-4651-81F4-D9D88AFE20F9Q39125016-51B29B1F-0495-41EA-ABDF-5090220323F8Q39156173-523EADC6-8703-432E-B711-F084B93ACCF8Q47155353-C55AADFD-2E7F-4A62-905D-070183EFF0F3Q50015077-22B31504-161D-4A23-B715-025B64B713F8Q52373765-4D954141-17C3-4663-8F5A-C9C6CB11294B
P2860
Engineering an analog-sensitive CDK12 cell line using CRISPR/Cas.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Engineering an analog-sensitive CDK12 cell line using CRISPR/Cas.
@en
type
label
Engineering an analog-sensitive CDK12 cell line using CRISPR/Cas.
@en
prefLabel
Engineering an analog-sensitive CDK12 cell line using CRISPR/Cas.
@en
P2093
P2860
P1476
Engineering an analog-sensitive CDK12 cell line using CRISPR/Cas.
@en
P2093
Arno L Greenleaf
Bartlomiej Bartkowiak
Christopher Yan
P2860
P304
P356
10.1016/J.BBAGRM.2015.07.010
P407
P577
2015-07-16T00:00:00Z